Acino International AG
https://acino.swiss.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Acino International AG
Celltrion Strikes $278m Deal With Takeda
Celltrion has bought a portfolio of selected products in the Asia-Pacific region from Takeda, marking a foray into small-molecule drugs.
Celltrion Expands In APAC, Small Molecules Via $278m Takeda Asset Buy
In continuing strategy to shed non-core assets globally, Japanese firm will sell portfolio of selected products in Asia-Pacific to Korean biosimilars giant Celltrion.
Takeda Sheds More Non-Core Assets, Employees In $670m Orifarm Deal
Danish firm picks up portfolio and manufacturing sites, along with around 600 employees.
Deal Watch: Lilly, AbCellera Partner To Attempt Rapid COVID-19 Antibody Development
Partnership will combine AbCellera’s screening of antibodies to the virus with Lilly’s development, commercial capabilities. Vir adds Biogen tie-up to its ongoing coronavirus efforts.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
-
Drug Delivery
- Controlled Release
- Other Names / Subsidiaries
-
- Acino Holding AG